Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS)
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Vanderbilt University Medical Center
- Study ID
- NCT07612644
- Status
- Recruiting
Conditions
- Lumbar Puncture
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Day - 12 Months
- Healthy Volunteers
- Not accepted
Interventions
- ultrasound contrast — DEVICEUltrasound of spinal canal without contrast. We included the term "ultrasound contrast" because the choices were limited.
Study Details
This is a clinical trial to determine the extent to which ultrasound-assisted lumbar puncture using a standardized procedure, including use of ultrasound to ascertain the presence of cerebrospinal fluid (CSF) at L3 - L5 and the optimal needle insertion distance, increases the acquisition rate of CSF that is interpretable for patient management.
Key Dates
- Start date
- May 16, 2026
- Status verified
- May 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: UltrasoundIntervention: Ultrasound of spinal canal
- No Intervention: Control GroupInfants undergoing lumbar puncture without ultrasound assist
Primary Outcome Measure
Successful LP rate [ Time Frame: Time from lumbar puncture to results of CSF returned by lab, approximately 1 hour. ]
Central Contacts
- Donald H Arnold, MD, MPH615-936-4498
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 |
Find similar trials in Nashville, TN
By research site